Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development-Reference-Cited by-同舟云学术

Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development

Published:2012-10-08 Issue:2 Volume:9 Page:176-188
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Boxer Adam L.¹,Gold Michael²,Huey Edward³,Gao Fen‐Biao⁴,Burton Edward A.⁵,Chow Tiffany⁶,Kao Aimee¹,Leavitt Blair R.⁷,Lamb Bruce⁸,Grether Megan⁹,Knopman David¹⁰,Cairns Nigel J.¹¹,Mackenzie Ian R.¹²,Mitic Laura⁹,Roberson Erik D.¹³,Van Kammen Daniel¹⁴,Cantillon Marc¹⁵,Zahs Kathleen¹⁶,Salloway Stephen¹⁷,Morris John¹¹,Tong Gary¹⁸,Feldman Howard¹⁹,Fillit Howard²⁰,Dickinson Susan²¹,Khachaturian Zaven²²,Sutherland Margaret²³,Farese Robert²⁴,Miller Bruce L.¹,Cummings Jeffrey²⁵

Affiliation:

1. Memory and Aging CenterDepartment of NeurologyUniversity of CaliforniaSan FranciscoCAUSA

2. Allon TherapeuticsVancouverBritish ColumbiaCanada

3. Department of NeurologyTaub Institute Columbia UniversityNew YorkNYUSA

4. Department of NeurologyUniversity of MassachusettsWorcesterMAUSA

5. Department of NeurologyUniversity of PittsburghPittsburghPAUSA

6. Rotman Research Institute University of TorontoTorontoOntarioCanada

7. Division of Neurology, Department of Medicine, Centre for Molecular Medicine and TherapeuticsUniversity of British ColumbiaVancouverBritish ColumbiaCanada

8. Department of NeurosciencesLerner Research Institute, Cleveland Clinic FoundationClevelandOHUSA

9. Bluefield Project to Cure Frontotemporal DementiaSan FranciscoCAUSA

10. Department of NeurologyMayo ClinicRochesterMNUSA

11. Department of NeurologyWashington University School of MedicineSt. LouisMOUSA

12. Department of Pathology and Laboratory MedicineUniversity of British ColumbiaVancouverBritish ColumbiaCanada

13. Department of NeurologyUniversity of Alabama School of MedicineBirminghamALUSA

14. CNS Drug Development ConsultantPrincetonNJUSA

15. Critical Path InstituteRockvilleMDUSA

16. Grossman Center for Memory Research and Care University of Minnesota School of MedicineMinneapolisMNUSA

17. Department of NeurologyBrown University School of MedicineProvidenceRIUSA

18. Bristol Myers SquibbPrincetonNJUSA

19. Division of Neurology, Department of MedicineUniversity of British ColumbiaVancouverBritish ColumbiaCanada

20. Alzheimer's Drug Discovery FoundationNew YorkNYUSA

21. Association for Frontotemporal DegenerationRadnorPAUSA

22. KRA AssociatesPotomacMDUSA

23. National Institutes of Health/National Institute of Neurological Disorders and StrokeBethesdaMDUSA

24. Gladstone Institute of Cardiovascular DiseaseSan FranciscoCAUSA

25. Cleveland Clinic Lou Ruvo Center for Brain HealthLas VegasNVUSA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2012.03.002

Reference74 articles.

1. Classification of primary progressive aphasia and its variants

2. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia;Rascovsky K;Brain,2011

3. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

4. The cytoskeleton in neurodegenerative diseases

5. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSF neurogranin levels as a biomarker in Alzheimer’s disease and frontotemporal lobar degeneration: a cross-sectional analysis;Alzheimer's Research & Therapy;2024-09-06

2. AI-based differential diagnosis of dementia etiologies on multimodal data;Nature Medicine;2024-07-04

3. Fully Human Bifunctional Intrabodies Achieve Graded Reduction of Intracellular Tau and Rescue Survival ofMAPTMutation iPSC-derived Neurons;2024-06-01

4. AI-based differential diagnosis of dementia etiologies on multimodal data;2024-02-11

5. Phase 1 study of latozinemab in progranulin‐associated frontotemporal dementia;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2024-01